Comparison of adjacent segment disease after minimally invasive or open transforaminal lumbar interbody fusion

被引:48
|
作者
Yee, Timothy J. [1 ]
Terman, Samuel W. [1 ]
La Marca, Frank [1 ]
Park, Paul [1 ]
机构
[1] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA
关键词
Adjacent segment disease; Minimally invasive; Spine surgery; TLIF; Transforaminal lumbar interbody fusion; 5-YEAR OUTCOMES; FACET VIOLATION; RISK-FACTORS; DEGENERATION; DISC; MINIMUM; STENOSIS; LEVEL; SPINE; SPONDYLOLISTHESIS;
D O I
10.1016/j.jocn.2014.03.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Adjacent segment disease (ASD) is a potential long-term risk after lumbar fusion. Its incidence has been evaluated in anterior and posterior lumbar interbody fusions, but few studies have focused on transforaminal lumbar interbody fusion (TLIF). Relative risk of ASD with open or minimally invasive (MI) TLIF is poorly understood. To report our experience with risk for ASD in patients receiving TLIF and test its association with surgical approach, we performed a retrospective cohort study based on medical record review at a single institution. Eligible patients were >= 18 years old at operation, underwent single-level TLIF during the period 2007-2008, and had at least 6 months postoperative follow-up. Patients were categorized by surgical approach (open versus MI). Primary outcome of interest was development of symptomatic ASD, defined by (1) new back and/or leg pain, (2) imaging findings adjacent to original surgical level, and (3) decision to treat. A total of 68 patients (16 open, 52 MI) were included in the analysis. Groups had similar baseline characteristics, except the open group tended to be older (p = 0.04). Seven (10%) patients developed ASD. Mean patient age was 62 years and three were male. Three underwent open and four underwent MI TLIF. Risk of ASD did not differ significantly by surgical approach. The MI group showed a trend toward decreased risk of ASD compared to the open group, although it was not statistically significant. This suggests MI TLIF may be associated with decreased long-term morbidity compared to the open approach. Large prospective studies are needed to confirm these findings. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1796 / 1801
页数:6
相关论文
共 50 条
  • [41] Iatrogenic muscle damage in transforaminal lumbar interbody fusion and adjacent segment degeneration: a comparative finite element analysis of open and minimally invasive surgeries
    Yogesh Kumaran
    Anoli Shah
    Akhil Katragadda
    Adit Padgaonkar
    Joseph Zavatsky
    Robert McGuire
    Hassan Serhan
    Hossein Elgafy
    Vijay K. Goel
    European Spine Journal, 2021, 30 : 2622 - 2630
  • [42] Comparison of the Clinical Outcome in Overweight or Obese Patients After Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion
    Wang, Jian
    Zhou, Yue
    Zhang, Zheng Feng
    Li, Chang Qing
    Zheng, Wen Jie
    Liu, Jie
    JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2014, 27 (04): : 202 - 206
  • [43] Minimally Invasive Transforaminal Lumbar Interbody Fusion and Unilateral Fixation for Degenerative Lumbar Disease
    Wang, Hui-wang
    Hu, Yong-cheng
    Wu, Zhan-yong
    Wu, Hua-rong
    Wu, Chun-fu
    Zhang, Lian-suo
    Xu, Wei-kun
    Fan, Hui-long
    Cai, Jin-sheng
    Ma, Jian-qing
    ORTHOPAEDIC SURGERY, 2017, 9 (03) : 277 - 283
  • [44] Comparison of the Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion and Endoscopic Transforaminal Lumbar Interbody Fusion for Lumbar Diseases: A Matched Case-Control
    Shi, Liang
    Ding, Tao
    Shi, Yihua
    Wang, Fang
    Wu, Chengcong
    WORLD NEUROSURGERY, 2022, 167 : E1231 - E1240
  • [45] Comparison between Oblique Lumbar Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MISTLIF) for Lumbar Spondylolisthesis
    Chandra, Vemula V. R.
    Prasad, Bodapati C. M.
    Hanu, Tammireddy G.
    Kale, Pavan G.
    NEUROLOGY INDIA, 2022, 70 (01) : 127 - 134
  • [46] Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion: Technique Note and Comparison of Early Outcomes with Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spondylolisthesis
    Zhang, Hao
    Zhou, Chuanli
    Wang, Chao
    Zhu, Kai
    Tu, Qihao
    Kong, Meng
    Zhao, Chong
    Ma, Xuexiao
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 549 - 558
  • [47] Reduced Acute Care Costs With the ERAS® Minimally Invasive Transforaminal Lumbar Interbody Fusion Compared With Conventional Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Wang, Michael Y.
    Chang, Hsuan Kan
    Grossman, Jay
    NEUROSURGERY, 2018, 83 (04) : 827 - 834
  • [48] Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion
    Meng Ge
    Yuan Zhang
    Hang Ying
    Chenchen Feng
    Yanlei Li
    Jinlong Tian
    Tingxiao Zhao
    Haiyu Shao
    Yazeng Huang
    International Orthopaedics, 2022, 46 : 2063 - 2070
  • [49] Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion
    Ge, Meng
    Zhang, Yuan
    Ying, Hang
    Feng, Chenchen
    Li, Yanlei
    Tian, Jinlong
    Zhao, Tingxiao
    Shao, Haiyu
    Huang, Yazeng
    INTERNATIONAL ORTHOPAEDICS, 2022, 46 (09) : 2063 - 2070
  • [50] Factors associated with readmission after minimally invasive transforaminal lumbar interbody fusion
    Tumialan, Luis M.
    Weinstein, Nolan
    Farber, S. Harrison
    Desai, Shashvat M.
    Marciano, Frederick F.
    JOURNAL OF NEUROSURGERY-SPINE, 2023, 38 (06) : 681 - 687